Authored By: Sarah
12 Feb 2025

Latest News- Sexually Transmitted Disease (STD) Testing Market: Laboratory testing device is expected to lead the Product segment during 2024-2028

The Sexually Transmitted Disease (STD) Testing Market is being driven by Increasing prevalence of STDs

The Sexually Transmitted Disease (STD) Testing Market is expected to grow at a CAGR of 5.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 32.37 billion. The Sexually Transmitted Disease (STD) testing market is experiencing a notable transition from conventional laboratory testing to rapid point-of-care (POC) testing. POC HIV testing, in particular, has gained widespread acceptance due to its ability to surmount patient and provider barriers to routine screening. The preference for self-testing for HIV is increasingly popular in developed nations. Home HIV test kits or self-testing in a domestic setting detect the presence of HIV-1/2 antibodies or HIV-1 p24 antigen. The effectiveness of POC testing is amplified by the emergence of sensors, microsystems, and affordable imaging technologies. Furthermore, the STD testing market is witnessing swift advancements in molecular diagnostics, which are increasingly being utilized for STD testing. 

Get more information on Sexually Transmitted Disease (STD) Testing Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on segments_for_ai.nslist

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

  • Increasing prevalence of STDs
  • Presence of favorable reimbursement policies
  • Increased initiatives by governments worldwide

However, the market also witnesses some limitations, which are as follows:

  • Limited healthcare services in developing regions
  • Social stigma associated with STDs
  • High cost of novel antiviral therapeutics

Benefits of Buying Global Sexually Transmitted Disease (STD) Testing Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Sexually Transmitted Disease (STD) Testing Market Research Report

Market Scope

Report Coverage

Details

Page number

176

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.6%

Market growth 2024-2028

USD 32.37 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

5.22

Key countries

US, Germany, UK, Canada, and China

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Sexually Transmitted Diseases (STD) diagnostics market encompasses the detection of various Infectious Diseases, including HIV, Gonorrhea, Syphilis, Hepatitis C virus, Human immunodeficiency virus (HIV), Human papillomavirus (HPV), Malaria, Tuberculosis, and AIDS. This market caters to the needs of Health Organizations, Hospitals and clinics, Diagnostic centers, and home-based tests. Technological advancements have led to the development of Point-of-Care (POC) testing, which allows for early disease detection at decentralized locations, as opposed to centralized laboratories. Some common STDs include HIV, Gonorrhea, Syphilis, Hepatitis C virus, Human papillomavirus (HPV), and AIDS statistics. Other diseases like Malaria and Tuberculosis are also diagnosed through this market.

Market Research Overview

The global life sciences tools and services market encompasses organizations involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables for pharmaceuticals and biotechnology, as well as laboratory diagnosis of infectious diseases such as HIV, Gonorrhea, and Syphilis. According to Technavio, this market's growth is attributable to several factors, including the increasing global population aging, resulting in a larger demographic susceptible to infectious diseases. Additionally, the advancement of point-of-care testing technology is expected to significantly impact the market, enabling faster and more accurate diagnosis of HIV, AIDS, and other infectious diseases. The global healthcare market size is calculated based on the combined revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.

Document